DimakakosELivaniosKGkiozosIet al.
New data for venous thromboembolism in patients with small cell lung cancer: a review.Phlebology2018;
33: 517–522.
2.
BlomJWDoggenCJOsantoSet al.
The risk of venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma.JAMA2005;
293: 715–722.
3.
AlcayAWunTKhatriVet al.
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.J Clinical Oncol2006;
24: 1112–1118.
4.
AgnelliGGeorgeDJ, Kakkaret al.
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.N Engl J Med2012;
366: 601–609.
5.
YoungAMMarshallAThirlwallJet al.
Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT- D).J Clin Oncol2018;
36: 2017–2023.
6.
SengSLiuZChiuSKet al.
Risk of venous thromboembolism in patients with cancer treated with cisplatin: a systematic review and meta-analysis.J Clin Oncol2012;
30: 4416–4426.
7.
KhoranaAAKudererNMCulakovaEet al.
Development and validation off a predictive model for chemotherapy-associated thrombosis. Blood2008;
111: 4902–4907.
